Literature DB >> 18199029

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

Ju Young Chang1, Dionysios A Antonopoulos, Apoorv Kalra, Adriano Tonelli, Walid T Khalife, Thomas M Schmidt, Vincent B Young.   

Abstract

Antibiotic-associated diarrhea due to Clostridium difficile (CDAD) is thought to reflect colonization of a disrupted microbial community by the pathogen. We profiled the fecal microbiota of patients with CDAD (both initial and recurrent episodes) by culture-independent phylogenetic analysis of 16S rRNA-encoding gene sequences. Compared with those from control subjects and patients with an initial episode, the fecal communities in patients with recurrent CDAD were highly variable in bacterial composition and were characterized by markedly decreased diversity. Preservation and restoration of the microbial diversity could represent novel strategies for prevention and treatment of recurrent CDAD, which is often recalcitrant to existing therapies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18199029     DOI: 10.1086/525047

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  416 in total

Review 1.  Minority report: the intestinal mycobiota in systemic infections.

Authors:  Thierry Rolling; Tobias M Hohl; Bing Zhai
Journal:  Curr Opin Microbiol       Date:  2020-06-27       Impact factor: 7.934

2.  Rapid changes in the gut microbiome during human evolution.

Authors:  Andrew H Moeller; Yingying Li; Eitel Mpoudi Ngole; Steve Ahuka-Mundeke; Elizabeth V Lonsdorf; Anne E Pusey; Martine Peeters; Beatrice H Hahn; Howard Ochman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

3.  Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota.

Authors:  Mary C Rea; Orla O'Sullivan; Fergus Shanahan; Paul W O'Toole; Catherine Stanton; R Paul Ross; Colin Hill
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

4.  Efficacious outcome employing fecal bacteriotherapy in severe Crohn's colitis complicated by refractory Clostridium difficile infection.

Authors:  C A Duplessis; D You; M Johnson; A Speziale
Journal:  Infection       Date:  2011-12-08       Impact factor: 3.553

Review 5.  The human microbiome and its potential importance to pediatrics.

Authors:  Coreen L Johnson; James Versalovic
Journal:  Pediatrics       Date:  2012-04-02       Impact factor: 7.124

6.  Transcriptional profiling of Clostridium difficile and Caco-2 cells during infection.

Authors:  Tavan Janvilisri; Joy Scaria; Yung-Fu Chang
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

7.  Hierarchical social networks shape gut microbial composition in wild Verreaux's sifaka.

Authors:  Amanda C Perofsky; Rebecca J Lewis; Laura A Abondano; Anthony Di Fiore; Lauren Ancel Meyers
Journal:  Proc Biol Sci       Date:  2017-12-06       Impact factor: 5.349

8.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

9.  Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study.

Authors:  Isabel Ruiz-Camps; Benito Almirante; Thais Larrainzar-Coghen; Dolors Rodríguez-Pardo; Pere Barba; Juan Aguilar-Company; Virginia Rodríguez; Gloria Roig; Carmen Ferrer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-02       Impact factor: 3.267

Review 10.  Clostridium Difficile Infection from a Surgical Perspective.

Authors:  Andreas M Kaiser; Rachel Hogen; Liliana Bordeianou; Karim Alavi; Paul E Wise; Ranjan Sudan
Journal:  J Gastrointest Surg       Date:  2015-04-28       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.